NCT02393378View on ClinicalTrials.gov

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate

PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 8, 2015

Primary Completion Date

June 27, 2016

Study Completion Date

November 16, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Namilumab

Namilumab injection

DRUG

Adalimumab

Adalimumab SC injection

DRUG

Methotrexate

Methotrexate tablet

DRUG

Folic Acid

Folic Acid Tablet

Trial Locations (13)

Unknown

Pardubice

Prague

Tallinn

Tartu

Moscow

Yaroslavl

Santiago de Compostela

Fuenlabrada

A Coruña

Madrid

London

Salford

Oxford

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY